Filter your results
- 3
- 3
- 3
- 1
- 2
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 studyBlood, 2015, 126 (12), pp.1415--1423. ⟨10.1182/blood-2015-03-635151⟩
Journal articles
hal-01231424v1
|
||
|
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of ageBritish Journal of Haematology, 2016, 174 (6), pp.887-898. ⟨10.1111/bjh.14140⟩
Journal articles
hal-01331987v1
|
||
|
Severe chronic primary neutropenia in adults: report on a series of 108 patientsBlood, 2015, 126 (14), pp.1643--1650. ⟨10.1182/blood-2015-03-634493⟩
Journal articles
hal-01255845v1
|